Table 1.
Strains | Biofilm formation at 24 h | Biofilm formation at 48 h | Metronidazole | Clindamycin | ||||
---|---|---|---|---|---|---|---|---|
MIC (mg/L) | Ratio of MBIC/MICat 24 h | Ratio of MBIC/MICat 48 h | MIC (mg/L) | Ratio of MBIC/MICat 24 h | Ratio of MBIC/MICat 48 h | |||
XB-06 | 0.39 ± 0.03 (N) | 1.65 ± 0.17 (M) | 128 | 2 (256/128) | 2 (256/128) | 0.0625 | 2 (0.125/0.0625) | 2048 (128/0.0625) |
XB-05 | 0.34 ± 0.04 (N) | 1.73 ± 0.18 (M) | 1 | 4 (4/1) | 16 (16/1) | 0.0625 | 2 (0.125/0.0625) | 2 (0.125/0.0625) |
XB-04 | 0.61 ± 0.07 (W) | 3.23 ± 0.61 (S) | 16 | 8 (128/16) | 16 (256/16) | 0.0625 | 4 (0.25/0.0625) | 2048 (128/0.0625) |
XB-03 | 0.35 ± 0.04 (N) | 1.81 ± 0.33 (M) | 0.125 | 8 (2/0.125) | 8 (2/0.125) | 0.0625 | 2 (0.125/0.0625) | 2 (0.125/0.0625) |
XB-02 | 0.34 ± 0.03 (N) | 2.20 ± 0.60 (M) | 0.125 | 1 (0.125/0.125) | 8 (1/0.125) | 0.0625 | 2 (0.125/0.0625) | 2 (0.125/0.0625) |
XB-01 | 0.37 ± 0.03 (N) | 2.50 ± 0.40 (M) | 2 | 4 (8/2) | 4 (8/2) | 0.0625 | 2 (0.125/0.0625) | 2 (0.125/0.0625) |
ATCC14018 | 0.97 ± 0.13 (M) | 2.32 ± 0.19 (M) | 16 | 4 (64/16) | 4 (64/16) | 0.0625 | 16 (1/0.0625) | 512 (32/0.0625) |
N, no biofilm producer; W, weak biofilm producer; M, moderate biofilm producer; S strong biofilm producer. The biofilm formation capacity at 48 h positively correlated with both ratios of MBIC/MIC in metronidazole (correlation coefficient = 0.601, p = 0.018) and the ratio of MBIC/MIC in clindamycin (correlation coefficient = 0.318, p = 0.000) at 48 h. The biofilm formation capacity at 24 h positively correlated with the ratio of MBIC/MIC in clindamycin at 24 h (correlation coefficient = 0.949, p = 0.000). No correlation was observed between the biofilm formation capacity at 24 h and the ratio of MBIC/MIC in metronidazole at 24 h (correlation coefficient = 0.350, p > 0.05).